What Happened this Week? Abbvie abandons Galapagos, CRISPR Patent war to end and AI to exploit UK’s 100k genomes

03/10/2015 - 1 minute

Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping)

Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments?

Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?

Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government

Friday: Merck relinquishes Rare Disease license to instead focus on Immuno-oncology

Weekend: We will celebrate German unity on Saturday.

reichstag-324982_1280

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
ADVERTISEMENT
Do you want to remove this advert? Become a member!
ADVERTISEMENT
Do you want to remove this advert? Become a member!

Support Us

Become a Member